Editorial Policy

The manuscripts will be reviewed for possible publication with the understanding that they are being submitted to one journal at a time. The Editors review all submitted manuscripts initially. Manuscripts with insufficient originality, serious scientific and technical flaws are rejected. All manuscripts received are duly acknowledged. Manuscripts are sent to two or more expert reviewers without revealing the reviewers. Each manuscript is also assigned to a member of the editorial team, who based on the comments from the reviewer manuscript. The contributors will be informed about the reviewers' comments and acceptance/rejection of manuscript. The average turnaround time is about 5 weeks. Articles accepted would be copy edited for grammar, punctuation, print style, and format. Page proofs will be sent to the correspondent to be returned within three days. Correction received after that period may not be included.

Clinical Trial Registry:
All clinical trials from India must be registered with “Clinical Trials Registry – India”. The trials conducted outside India may be registered with the CT registry. The Indian council of medical research has recommended making it mandatory to have registration number for all clinical trials after January 2009.

Contribution Details:
Contributors should provide a description of what each of them contributed towards the manuscript. Description should be divided applicable: concepts, design, definition of intellectual content, literature search, clinical studies, experimental studies, data acquisition, analysis, manuscript preparation, manuscript editing and manuscript review. Authors' contributions will be printed on the first page, they should take responsibility of the integrity of the work as a whole from inception to published article.

Conflicts of Interest:
All authors of submitting articles to the journal must disclose any conflict of interest they may have with an institution or product that is involved and/or is important to the outcome of the study presented.

Authorship Criteria
Authorship credit should be based only on substantial contributions
  • Conception and design or acquisition of data or analysis and interpretation of data;
  • Drafting the article or revising it critically for important intellectual content;
  • Final approval of the version to be published.
Conditions 1, 2, and 3 must be met. Participation solely in the acquisition of funding or the collection of data does not justify authorship. Each contributor should have participated sufficiently in the work to take public responsibility for the study and the order of naming the contributors should be based on the relative contribution of the contributor towards the study and writing the man cannot be changed without written consent of all the contributors. For a case-report, brief communication, the number of contributors should not exceed four. A justification should be included, if the number of contributors exceeds these limits. Only those who have done substantial work in a particular field can write a review article. The journal expects the contributors to give post-publication updates on the subject of review. The update in the field after the publication of article and should be sent as a letter to editor, as and when major development occurs in the field.

Types of Manuscripts and Limits
  1. Original articles: Randomized controlled trials, intervention studied, studies of screening and diagnostic test, outcome studies, case-control series, and surveys with high response rate. Up to 3000 words excluding about 30 references and abstract.
  2. Review articles (including for Ethics forum, Education forum, E-Medicine, etc.): Systemic critical assessments of literature and excluding about 90 references and abstract. For review articles, include the method (literature search) in abstract as well as in articles are invited by the Editor-in-chief from people of eminence with vast personal experience in the field.
  3. Case reports: new/interesting/very rare cases can be reported. Cases with clinical significance or implications will be given priority. Up to 1000 words excluding references and abstract and up to 10 references. Case reports must meet all of the following criteria:
    1. The case should be one that is highly unusual, very unique, underreported.
    2. The report must present as a challenging diagnostic and therapeutic problem and;
    3. the case report must have significant educationally, perhaps change a clinician's traditional method of handling such a case and;
    4. the case report's interest to the reader should be explained. Preparation of Case Reports Follow the standard format for the article (Abstract, Key-words, Introduction, Case History, Discussion and References).
  4. Letter to the Editor: Should be short, decisive observation.
  5. Announcements of conferences, meetings, courses, and other items likely to be of interest to the readers should be submitted with information of person from whom additional information can be obtained. Editorial, and Review article are solicited by the editorial board. Protection of Patients' Rights to Privacy Identifying information should not be published in written descriptions, photographs, sonograms, CT scans, etc., Authors should mask names from figures unless they obtain written consent from the patients and submit written consent with the manuscript.